| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $0.41 (Beat by $0.0267) |
| EPS GAAP Actual | $0.41 (Beat by $0.0267) |
| Revenue Actual | $1.688B |
| Revenue Surprise | Beat by $1688M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.55 |
| EPS GAAP Estimate | $0.55 |
| Revenue Estimate | $1.945132525B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 3.12 | 13.45 | 3.02727 | 3.28193 | 3 |
| Dec 2028 | 4.41 | 9.51 | 4.24803 | 4.76017 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.45 | -0.1515 | 1.688B | -3.02% | -261.56M |
| FQ2 2025 (Jun 2025) | 0.41 | -0.07386 | 1.688B | 3.32% | -129.73M |
| FQ1 2025 (Mar 2025) | 0.38 | 0.03929 | 1.585B | 2.27% | -149.75M |
| FQ4 2024 (Dec 2024) | -1.32 | -1.69571 | 1.83B | -1.31% | 27.33M |
| FQ3 2024 (Sep 2024) | 0.32 | -1.22141 | 1.739B | -6.5% | -2412.25M |
| FQ2 2024 (Jun 2024) | 0.28 | 0.28 | 1.632B | -13.05% | 1632M |
| FQ1 2020 (Mar 2020) | -0.53 | -0.53 | 1.34874B | 100% | 1348.74M |
| FQ2 2020 (Jun 2020) | -0.53 | -0.53 | 1.34874B | 100% | 1348.74M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.55
Consensus Revenue Estimates
1.945132525B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.95 | -- | 0.93662 | 1.0106 | 8 |
| FQ3 2027 (Sep 2027) | 0.94 | -- | 0.92676 | 0.99996 | 8 |
| FQ2 2027 (Jun 2027) | 0.74 | -- | 0.72958 | 0.7872 | 8 |
| FQ1 2027 (Mar 2027) | 0.62 | -- | 0.61127 | 0.65955 | 8 |
| FQ4 2026 (Dec 2026) | 0.8625 | -- | 0.85006 | 0.87604 | 9 |
| FQ3 2026 (Sep 2026) | 0.86785 | 48.15 | 0.84529 | 0.89376 | 4 |
| FQ2 2026 (Jun 2026) | 0.74049 | 44.63 | 0.72124 | 0.7626 | 4 |
| FQ1 2026 (Mar 2026) | 0.55 | 30.91 | 0.54207 | 0.55863 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.23B | -- | 2.2B | 2.34B | 5 |
| FQ3 2027 (Sep 2027) | 2.26B | -- | 2.23B | 2.37B | 8 |
| FQ2 2027 (Jun 2027) | 2.03B | -- | 2.01B | 2.13B | 5 |
| FQ1 2027 (Mar 2027) | 1.88B | -- | 1.86B | 1.98B | 5 |
| FQ4 2026 (Dec 2026) | 2.29B | -- | 2.26B | 2.32B | 9 |
| FQ3 2026 (Sep 2026) | 2.15B | 21.64 | 2.11B | 2.2B | 4 |
| FQ2 2026 (Jun 2026) | 1.97B | 14.29 | 1.93B | 2.01B | 4 |
| FQ1 2026 (Mar 2026) | 1.95B | 18.51 | 1.92B | 1.97B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.6015 | 0.45 | -0.1515 | -33.67% |
| FQ2 2025 (Jun 2025) | 0.48386 | 0.41 | -0.07386 | -18.01% |
| FQ1 2025 (Mar 2025) | 0.34071 | 0.38 | 0.03929 | 10.34% |
| FQ4 2024 (Dec 2024) | 0.37571 | -1.32 | -1.69571 | 128.46% |
| FQ3 2024 (Sep 2024) | 1.54141 | 0.32 | -1.22141 | -381.69% |
| FQ2 2024 (Jun 2024) | 0.28 | 0.28 | 100% | |
| FQ1 2020 (Mar 2020) | -0.53 | -0.53 | 100% | |
| FQ2 2020 (Jun 2020) | -0.53 | -0.53 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.95B | $1.69B | $-261.56M | -15.49% |
| FQ2 2025 (Jun 2025) | $1.82B | $1.69B | $-129.73M | -7.69% |
| FQ1 2025 (Mar 2025) | $1.73B | $1.59B | $-149.75M | -9.45% |
| FQ4 2024 (Dec 2024) | $1.8B | $1.83B | $27.33M | 1.49% |
| FQ3 2024 (Sep 2024) | $4.15B | $1.74B | $-2412.25M | -138.71% |
| FQ2 2024 (Jun 2024) | $0B | $1.63B | $1632M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $1.35B | $1348.74M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $1.35B | $1348.74M | 100% |